In focus · trending topic

Aptose

24 stories · following the connections

Aptose Exercises Early Option for CG-806 License From CrystalGenomics

By Nasdaq OMXMay 7, 2018, 11:01 AM UTC

Aptose To Release First Quarter Ended March 31, 2018 Financial Results and Hold Conference Call on May 10, 2018

By Nasdaq OMXMay 1, 2018, 11:30 AM UTC

Aptose Announces Appointment of Caroline M. Loewy to Board of Directors

By Nasdaq OMXApr 25, 2018, 11:00 AM UTC

Aptose to Present at the Bloom Burton & Co. Healthcare Investor Conference 2018

By Nasdaq OMXApr 24, 2018, 11:00 AM UTC

Aptose Presents Preclinical Data on APTO-253 at 2018 AACR Annual Meeting

By Nasdaq OMXApr 17, 2018, 6:00 PM UTC

OHSU and Aptose Present New CG’806 Preclinical Data at 2018 AACR Annual Meeting

By Nasdaq OMXApr 16, 2018, 11:30 AM UTC

Aptose Presents New Preclinical Data on CG’806 Pan-FLT3/ Pan-BTK Inhibitor at 2018 AACR Annual Meeting

By Nasdaq OMXApr 16, 2018, 11:30 AM UTC

Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference

By Nasdaq OMXApr 3, 2018, 12:01 PM UTC